Hand-foot-skin reaction is a distinct clinical condition arising in association with the use of multikinase inhibitors, including sorafenib. Because multikinase inhibitors are increasingly being used in children with cancer, recognition of this previously unfamiliar condition is of importance to pediatric dermatologists. We describe the diagnosis and successful treatment of a case of hand-foot-skin reaction in a child taking sorafenib for an unresectable desmoid tumor.
Keywords: hand-foot skin reaction; hyperkeratotic lesions; keratolytics; multikinase inhibitors; sorafenib; topical corticosteroids.
© 2018 Wiley Periodicals, Inc.